论文部分内容阅读
我院自1995年7月~1999年1月应用北京南华制药有限公司研制的长春酸胺(Vindesin,商品名为西文克,VDS)、DDP为主的联合化疗方案治疗晚期非小细胞肺癌51例,现将资料完整的34例治疗结果报告如下。1;陆床资料本组34例均经病理组织学或细胞学检查证实为非小细胞肺癌。男ZI例,
In our hospital from July 1995 to January 1999, a combination chemotherapy regimen based on Vindesin (Vindesin, VDS) and DDP developed by Beijing Nanhua Pharmaceutical Co., Ltd. was used to treat advanced non-small cell lung cancer. 51 For example, the complete 34 treatment results are reported below. 1; ground-bed data in this group of 34 cases were confirmed by histological or cytological examination of non-small cell lung cancer. Male ZI cases,